Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04064450 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MyoVasc Study on the Development and Progression of Heart Failure

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Apr 2028 to Dec 2028
    • Publications: details revised at 3 of 8 entries
    v4
  2. Primary endpoint revised
    • Secondary endpoints revised (23)
    • Publications: 5 to 8
    v3
  3. Secondary endpoints: details revised at 21 of 23 entriesv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The MyoVasc - Study is an observational, prospective cohort study. The study is investigating the development and progression of the heart failure syndrome, phenotypes of the heterogeneous syndrome, and the interactions of phenotypes with the vasculature regarding their impact for the course of heart failure.
Trial Details
NCT Number NCT04064450
Lead Sponsor Johannes Gutenberg University Mainz
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 3,289 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov